Valetudo Therapeutics LLC

13D and 13G Filings

Issuer	Symbol	CUSIP	% of Class	Shares	Form	Filed
Liminatus Pharma, Inc. 13D/A Amendment 1 LIMN · 53271X108	LIMN	53271X108	14.3%	9,617,954	13D/A Amendment 1	7/14/2026 Event 7/2/2026
Valetudo Therapeutics LLC			14.3%	9,617,954
Chris Kim			14.3%	9,617,954
Liminatus Pharma, Inc. 13D LIMN · 53271X108	LIMN	53271X108	23.7%	6,169,406	13D	5/7/2025 Event 4/30/2025
Valetudo Therapeutics LLC			23.7%	6,169,406
Chris Kim			23.7%	6,169,406

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.